September 26, 2024

The Fall 2024 advocacy blog Considering Clinical Trials is now available

August 29, 2024

How the CompassHER2 pCR trial (EA1181) and other novel studies seek to optimize HER2+ breast cancer management

August 21, 2024

How a patient’s role in a clinical trial for acute lymphocytic leukemia brought a cancer-free diagnosis, FDA approval

August 21, 2024

The implications of the E3311 trial in HPV+ head and neck cancer: Dr. Ranee Mehra

August 20, 2024

Blinatumomab improves 3-year overall survival in B-ALL versus chemotherapy (study E1910)

August 17, 2024

Nivolumab’s role in esophageal cancer neoadjuvant therapy: Dr. Jennifer Eads (study EA2174)

August 1, 2024

Advocate Health Care and Aurora Health Care cancer clinics join the EAQ211 trial, which seeks to determine why young lymphoma survivors are at high risk for other health problems

July 9, 2024

ECOG-ACRIN research advocate and prostate cancer survivor Brian Jones is profiled in Cancer Today

July 2, 2024

The Summer 2024 advocacy blog, Considering Clinical Trials, is now available

ECOG-ACRIN Cancer Research Group